A systematic review of the social and economic burden of influenza in low- and middle-income countries

Vaccine

Volumn 33, Issue 48, 2015, Pages 6537-6544

  de Francisco Shapovalova, Natasha ^a   Donadel, Morgane ^a   Jit, Mark ^b,c   Hutubessy, Raymond ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Broader economic impact; Cost; Developing countries; Economic evaluations; Influenza; Low and middle income countries; Systematic review

Indexed keywords

CASE MANAGEMENT; COST BENEFIT ANALYSIS; FLU LIKE SYNDROME; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INFLUENZA; INVESTMENT; LOWEST INCOME GROUP; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PRODUCTIVITY; REVIEW; SEASONAL INFLUENZA; SOCIAL STATUS; CARIBBEAN; COST OF ILLNESS; DEVELOPING COUNTRY; ECONOMICS; FAR EAST; FEMALE; HEALTH; INCOME; INFLUENZA, HUMAN; POVERTY; PREGNANCY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CARIBBEAN REGION; COST OF ILLNESS; DEVELOPING COUNTRIES; FAR EAST; FEMALE; GLOBAL HEALTH; HEALTH EXPENDITURES; HUMANS; INCOME; INFLUENZA, HUMAN; POVERTY; PREGNANCY;

EID: 84951567698     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.066     Document Type: Review

References (61)

1. Nair H., Brooks W.A., Katz M., Roca A., Berkley J.A., Madhi S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378(December (9807)):1917-1930. [Epub November 10, 2011]. 10.1016/S0140-6736(11)61051-9.
2. WHO Summary of the November 2013 GAVI Alliance Board meeting 2013, http://www.who.int/immunization/sage/meetings/2014/april/1_Executive_summary_GAVI_Alliance:Board_Nov13.pdf.
3. Peasah S.K., Azziz-Baumgartner E., Breese J., Meltzer M.I., Widdowson M.A. Influenza cost and cost-effectiveness studies globally - a review. Vaccine 2013, 31(November (46)):5339-5348. [Epub September 19, 2013]. 10.1016/j.vaccine.2013.09.013.
4. Ott J.J., Klein Breteler J., Tam J.S., Hutubessy R.C., Jit M., de Boer M.R. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Hum Vaccin Immunother 2013, 9(July (7)):1500-1511. [Epub May 31, 2013]. 10.4161/hv.24704.
5. World Bank World bank country and lending groups 2015, http://www.who.int/immunization/sage/meetings/2014/april/1_Executive_summary_GAVI_Alliance:Board_Nov13.pdf.
6. Deogaonkar R., Hutubessy R.C., van der Putten I., Evers S., Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012, October (12):878. 10.1186/1471-2458-12-878.2012.
7. Jit M., Hutubessy R., Png M.E., Sundaram N., Audimulam J., Salim S., et al. The broader economic impact of vaccination: reviewing and appraising the strength of evidence. BMC Med 2015, 13:209. 10.1186/s12916-015-0446-9.
8. Purchasing power parities (PPP) conversion factor, local currency unit to international dollar 2015, http://unstats.un.org/unsd/mdg/SeriesDetail.aspx?srid=699.
9. US Consumer Price Index (CPI). US consumer price index (CPI). http://www.bls.gov/cpi/.
10. Walker D.G., Hutubessy R.C., Beutels P. WHO guide for standardisation of economic evaluations of immunization programmes. Vaccine 2010, 28(March (11)):2356-2359. [Epub June 28, 2009]. 10.1016/j.vaccine.2009.06.035.
11. Gold Marthe R. Cost-effectiveness in health and medicine 1996.
12. Bärnighausen T., Bloom D.E., Cafiero-Fonseca E.T., O'Brien J.C. Valuing vaccination. Proc Natl Acad Sci U S A 2014, 111(August (34)):12313-12319. [Epub August 18, 2014]. 10.1073/pnas 1400475111.
13. Rajatonirina S., Heraud J.M., Randrianasolo L., Orelle A., Razanajatovo N.H., Raoelina Y.N., et al. Short message service sentinel surveillance of influenza-like illness in Madagascar, 2008-2012. Bull World Health Organ 2012, 90(May (5)):385-389. 10.2471/BLT.11.097816.
14. Randrianasolo L., Raoelina Y., Ratsitorahina M., Ravolomanana L., Andriamandimby S., Heraud J.M., et al. Sentinel surveillance system for early outbreak detection in Madagascar. BMC Public Health 2010, 10:31.
15. Lahariya C., Sharma A.K., Pradhan S.K. Avian flu and possible human pandemic. Indian Pediatr 2006, 43(April (4)):317-325.
16. Simmerman J.M., Chittaganpitch M., Erdman D., Sawatwong P., Uyeki T.M., Dowell S.F. Field performance and new uses of rapid influenza testing in Thailand. Int J Infect Dis 2007, 11(March (2)):166-171. [Epub June 23, 2006] 2007;23(2):182-7.
17. Wishnick E. Dilemmas of securitization and health risk management in the People's Republic of China: the cases of SARS and avian influenza. Health Policy Plan 2010, 25(November (6)):454-466.
18. Porras-Ramírez A., Alvis-Guzmán N., Rico-Mendoza A., Alvis-Estrada L., Castañeda-Orjuela C.A., Velandia-González M.P., et al. Cost effectiveness of influenza vaccination in children under 2 years old and elderly in Colombia. Rev Salud Publica (Bogota) 2002, 11(5):689-699.
19. Plun-Favreau J., Tasset-Tisseau A., Lundkvist J., Jonsson L., de la Llave G., Marty A. Influenza vaccination of the at-risk adults and elderly: measuring the long-term cost-effectiveness in an Argentinean Managed Care Organization. Int Congr Ser 2004, 1263(June):605-609.
20. Zhou L., Situ S., Huang T., Hu S., Wang X., Zhu X., et al. Direct medical cost of influenza-related hospitalizations among severe acute respiratory infections cases in three provinces in China. PLOS ONE 2013, 8(5):e63788.
21. Dayan G.H., Nguyen V.H., Debbag R., Gomez R., Wood S.C. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001, 19(July (30)):4204-4213.
22. Giglio N.D., Castellano V.E., Ruttimann R.W., Vidal G.I. Gentile Ãn. Epidemia de influenza del ano 2009 en un hospital pediatrico y costos medicos directos en menores de 5 anos comparados con el periodo 2006-2008. Arch Argent Pediatr 2002, 110(1):19-26.
23. Giglio N., Gentile A., Lees L., Micone P., Armoni J., Reygrobellet C., et al. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. Hum Vaccin Immunother 2012, 8(March (3)):312-322.
24. Zhang T., Zhu Q., Zhang X., Ding Y., Steinhoff M., Black S., et al. The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China. PLoS ONE 2012, 7(9):e44391.
25. Chicaiza-Becerra L.A., Garcia-Molina M., Ballesteros M., Gamboa O., Diaz J., Vega R. Economic evaluation of influenza vaccine applied to health personnel attending hospitalised oncological patients. Rev Salud Publica (Bogota) 2008, 10(November (5)):756-766.
26. Gutierrez J.P., Bertozzi S.M. Vacunacion contra influenza para adultos mayores en Mexico: consideraciones economicas. Influenza vaccination in the elderly population in Mexico: economic considerations. Salud Publica Mex 2002, 47(3):234-239.
27. Choconta-Piraquive L.A., Alvis GnN, De la Hoz R.F. Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia. Rev Panam Salud Publica 2002, 31(6):447-453.
28. Jerez Rodríguez H. Cost of influenza burden among employers of the ESE Hospital Universitario Ramón González Valencia, 1999. MedUNAB 2000, 3(9).
29. Burckel E., Ashraf T., de Sousa Filho J.P., Forleo Neto E., Guarino H., Yauti C., et al. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Pharmacoeconomics 1999, 16(November (5 Pt 2)):563-576.
30. Simmerman J.M., Lertiendumrong J., Dowell S.F., Uyeki T., Olsen S.J., Chittaganpitch M., et al. The cost of influenza in Thailand. Vaccine 2006, 24(May (20)):4417-4426.
31. Xing L.H., Ge C.M., Xing L.J. Cost-benefit analysis of influenza vaccination in Rizhao City, Shangdong Province, China. Chin J Biol 2008, 21(8):692-694.
32. Guo R.N., Zheng H.Z., Huang L.Q., Zhou Y., Zhang X., Liang C.K., et al. Epidemiologic and economic burden of influenza in the outpatient setting: a prospective study in a subtropical area of China. PLoS ONE 2012, 7(7):e41403.
33. Guo R.N., Zheng H.Z., Li J.S., Sun L.M., Li L.H., J.Y.Lin, et al. A population-based study on incidence and economic burden of influenza-like illness in south China, 2007. Public Health 2011, 125(June (6)):389-395.
34. Mota N.V., Lobo R.D., Toscano C.M., Pedroso de Lima A.C., Souza Dias M.B., Komagata H., et al. Cost-effectiveness of sick leave policies for health care workers with influenza-like illness, Brazil, 2009. Emerg Infect Dis 2011, 17(August (8)):1421-1429.
35. Feng L., Mounts A.W., Feng Y., Luo Y., Yang P., Feng Z., et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine 2010, 28(September (41)):6778-6782.
36. Gonzalez-Canudas J., Iglesias-Chiesa J.M., Romero-Antonio Y., Chavez-Cortes C., Gay-Molina J.G., Rivas-Ruiz R. Cost-effectiveness in the detection of influenza H1N1: clinical data versus rapid tests. Rev Panam Salud Publica 2011, 29(January (1)):1-8.
37. Zhao G.M., Chen J., Zhang T., Cai H., Wang D., Gu B.K., et al. A cost-benefit analysis of the influenza H1N1 vaccination in the primary and junior school in Shanghai. Zhonghua Yu Fang Yi Xue Za Zhi 2011, 45(August (8)):737-741.
38. Ong M.P., Sam I.C., Azwa H., Mohd Zakaria I.E., Kamarulzaman A., Wong M.H., et al. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect 2010, 61(November (5)):440-442.
39. Clague B., Chamany S., Burapat C., Wannachaiwong Y., Simmerman J.M., Dowell S.F., et al. A household survey to assess the burden of influenza in rural Thailand. Southeast Asian J Trop Med Public Health 2006, 37(May (3)):488-493.
40. Santoroa N., Tasset-Tisseau A., Nicoloyanisc N., Armonid J. Nine years of influenza vaccination in an Argentinean company: costs and benefits for the employer. Int Congr Ser 2004, 1263(2004):590-594.
41. Kuzminikh S., Zomarev A. Evaluation of epidemiologic, immune and economic effectiveness of Grippol vaccine. Collected presentations for the West-Ural region's scientific conference 2013.
42. Samad A.H., Usul M.H., Zakaria D., Ismail R., Tasset-Tisseau A., Baron-Papillon F., et al. Workplace vaccination against influenza in Malaysia: does the employer benefit?. J Occup Health 2006, 48(January (1)):1-10.
43. Gendon Y. Vaxigrip: epidemiologic and economic efficacy - systematic review. Vaccination 2000, 11(September/October (Suppl. 5)).
44. Wood S.C., Alexseiv A., Nguyen V.H. Effectiveness and economical impact of vaccination against influenza among a working population in Moscow. Vaccine 1999, 17(October (Suppl. 3)):S81-S87.
45. Apisarnthanarak A., Puthavathana P., Kitphati R., Auewarakul P., Mundy L.M. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008, 29(August (8)):777-780.
46. Apisarnthanarak A., Mundy L.M., Outbreak of influenza A H1N1 among Thai healthcare workers: is it time to integrate a vaccination program?. Infect Control Hosp Epidemiol 2010, 31(8):854-856.
47. Apisarnthanarak A., Uyeki T.M., Puthavathana P., Kitphati R., Mundy L.M. Reduction of seasonal influenza transmission among healthcare workers in an intensive care unit: a 4-year intervention study in Thailand. Infect Control Hosp Epidemiol 2010, 31(October (10)):996-1003.
48. Morales A., Martinez M.M., Tasset-Tisseau A., Rey E., Baron-Papillon F., Follet A. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective. Value Health 2004, 7(July (4)):433-441.
49. Lytkina I., Malyshev N. Prevention and treatment of flu and ARI among key target groups. Lechaschij vrach 2013.
50. Martynuk R. Economic burden of influenza in Russia 2013, Rospotrebnadzor.
51. Coker R.J., Hunter B.M., Rudge J.W., Liverani M., Hanvoravongchai P. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet 2011, 377(February (9765)):599-609.
52. Sarikaya O., Erbaydar T. Avian influenza outbreak in Turkey through health personnel's views: a qualitative study. BMC Public Health 2007, 7:330.
53. Smith R.D., Keogh-Brown M.R. Macroeconomic impact of a mild influenza pandemic and associated policies in Thailand, South Africa and Uganda: a computable general equilibrium analysis. Influenza Other Respir Viruses 2013, 7(November (6)):1400-1408. [Epub July 4, 2013]. 10.1111/irv.12137.
54. Herington J. Securitization of infectious diseases in Vietnam: the cases of HIV and avian influenza. Health Policy Plan 2010, 25(November (6)):467-475. 10.1093/heapol/czq052.
55. Romani M.H., Musharrafieh U.M., Lakkis N.A., Hamadeh G.N. Family physicians beliefs and attitudes regarding adult pneumococcal and influenza immunization in Lebanon. Fam Pract 2011, 28(December (6)):632-637.
56. Kakkar M., Hazarika S., Zodpey S., Reddy K.S. Influenza pandemic preparedness and response: a review of legal frameworks in India. Indian J Public Health 2010, 54(January (1)):11-17.
57. Moreno J., De la Hoz F., Rico A., Cotes K., Porras A. Flu vaccine effectiveness: a metaanalysis. Biomedica 2009, 29(March (1)):87-97.
58. Hanvoravongchai P., Chavez I., Rudge J.W., Touch S., Putthasri W., Chau P.N., et al. An analysis of health system resources in relation to pandemic response capacity in the Greater Mekong Subregion. Int J Health Geogr 2012, 11:53.
59. Aballéa S., Chancellor J., Martin M., Wutzler P., Carrat F., Gasparini R., et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health 2007, March (10)(2):98-116.
60. Portnoy A., Jit M., Lauer J., Blommaert A., Ozawa S., Stack M., et al. Estimating costs of care for meningitis infections in low- and middle-income countries. Vaccine 2015, 33S:A240-A247.
61. WHO WHO pandemic influenza preparedness (PIP) framework 2015, http://www.who.int/influenza/pip/en/.